期刊
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY
卷 20, 期 5, 页码 941-957出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.bpg.2006.04.004
关键词
oesophageal cancer; neoadjuvant therapy; therapy response assessment; CT; EUS; FDG-PET
Neoadjuvant or adjuvant multimodality therapy in oesophageal cancer is introduced in an effort to improve prognosis. However, in a substantial fraction of patients there is no response to this non-surgical therapy. Non-invasive imaging modalities such as computed tomography (CT), endoscopic ultrasound (EUS) and 18F-2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) have been evaluated for assessing patient response to therapy, and these are described in this review. Currently, FDG-PET seems to be the best available tool for neoadjuvant therapy response assessment in oesophageal cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据